Archives Of Family Medicine – November 1992

Click here to see the details and full-size version in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

In PNH, their most vital organ is exploding.

What will you do?

Reduce chronic hemolysis ??? the underlying cause of progressive morbidities and mortality in PNH.

Visit us at PNHsource.com to learn more.

Paroxysmal nocturnal hemoglobinuria (PNH), sometimes referred to as Marchiafava-Micheli syndrome, is a rare, acquired, potentially life-threatening disease of the blood characterised by complement-induced hemolytic anemia (anemia due to destruction of red blood cells in the bloodstream), red urine (due to the appearance of hemoglobin in the urine) and thrombosis. PNH is the only hemolytic anemia caused by an acquired (rather than inherited) intrinsic defect in the cell membrane (deficiency of glycophosphatidylinositol leading to absence of protective proteins on the membrane). It may develop on its own (“primary PNH”) or in the context of other bone marrow disorders such as aplastic anemia (“secondary PNH”).

More on Wikipedia

Brand name: PNH Source
Generic name/category: Disease awareness, web portal
Company: Alexion Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Paroxysmal nocturnal hemoglobinuria (PNH)
Target: Healthcare Professionals (HCP)
Tagline: Innovators in complement inhibition
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – September 17, 2009

To see all of this brand's ads on AdPharm, click here
0 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

Fibromyalgia pain is real. And so is treatment with Lyrica

Lyrica is the first treatment indicated in Canada for the management of pain associated with fibromyalgia in adults.

Brand name: Lyrica
Generic name/category: Pregabalin, Anticonvulsant
Company: Pfizer
Country/Market: Canada, North America
Indication(s)/use: Fibromyalgia, pain management
Target: Healthcare Professionals (HCP)
Tagline: Fibromyalgia pain is real. And so is treatment with Lyrica
Medium: Print ad
Size/duration: single-page
Publication/Aired: New England Journal of Medicine (NEJM) – August 27, 2009

To see all of this brand’s ads on AdPharm, click here

the Italian info organisation fighting Aids/HIV

HIV
It could happen to everyone, don’t discriminate.

Art Director/Copywriter: Andrea Castelletti
Photographer: Matteo Engolli.

Generic name/category: Disease awareness, public service
Company: LILA (Lega Italiana per la Lotta contro l’Aids)
Country/Market: Italy, Europe
Indication(s)/use: HIV, AIDS
Target: Consumers (DTC)
Publication: 2009